- This event has passed.
Sex/gender Specific COVID 19 Outcomes and Management Relevant for Heart, Lung, Blood, and Sleep Disorders: From Bench to Bedside
June 16 - June 17
Join the National Heart, Lung, and Blood Institute for a virtual scientific event on June 16-17, 2022 that looks at the differences in COVID-19 outcomes due to sex and gender. This NIH workshop, hosted by NHLBI, brings together basic and clinical scientists to review the state of the science in sex/gender differences in COVID-19 outcomes relevant to heart, lung, blood, and sleep (HLBS) disorders. Specifically, the workshop aims to identify key knowledge gaps and explore research opportunities to improve our understanding of these differences in COVID-19 outcomes. This knowledge may improve our ability to tailor prevention, intervention, and implementation strategies for COVID-19-related HLBS disorders.
Scientific collaborators from the NIH Office of Research on Women’s Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Minority and Health Disparities, and National Institute of Allergy and Infectious Diseases will complement the NHLBI perspective on the research landscape.
David Goff, M.D., Ph.D., NHLBI Director of the Division of Cardiovascular Sciences, and Janine A. Clayton, M.D., NIH Associate Director for Research on Women’s Health and Director of the NIH Office of Research on Women’s Health, will provide opening remarks.
Keynote: Sabine Oertelt-Prigione, M.D., Ph.D., MSc.P.H., of Radboud University in the Netherlands will give the keynote talk on the epidemiology of COVID-19 focusing on sex and gender. A leader in the field of sex/ gender-sensitive research, she currently is examining ways to investigate gender in medical research and implement sex- and gender-sensitive research into practice.
Mechanisms of sex disparities in COVID-19 outcomes
Impact of social determinants of health on gender-related COVID-19 HLBS outcomes
Pregnancy and other conditions that affect susceptibility to SARS-CoV-2
Cardiovascular and metabolic aspects of COVID-19